Navigation Links
AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides
Date:7/19/2010

VIENNA, July 19 /PRNewswire-USNewswire/ -- "This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna.

"We believe that the most responsible plan of action now is to quickly and efficiently articulate the sequence of steps necessary for confirmation and follow-up of these results, while also aggressively planning for potential roll-out of a licensable product."

"It will take time and resources to fully analyze and understand the data, but this proof of concept demands immediate action both in South Africa where there are a range of key, context-specific issues—and on a global level where this new evidence will energize and redirect the microbicide field as well as the broader arena of prevention strategies based on anti-HIV drugs. Simultaneous efforts on many fronts are needed to eventually realize the public health potential suggested by these data."

"We congratulate the trial sponsors, scientific collaborators, and partners who conducted this trial, and especially want to thank the nearly 900 South African women whose altruism and commitment as trial volunteers made this effort possible. These volunteers and their communities have made an inestimable contribution to HIV prevention research and to the eventual development of new ways for women and men all over the world to protect themselves from HIV. We owe them an enormous debt of gratitude," Warren said.

"As we mo
'/>"/>

SOURCE AIDS Vaccine Advocacy Coalition
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study
2. Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimers Disease at International Conference on Alzheimers Disease (ICAD)
3. American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy
4. Innocoll Submits SPA for Cogenzia(TM) Phase III Clinical Trials for the Adjuvant Treatment of Diabetic Foot Infections
5. Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States
6. Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
7. Sylentis Completes Phase I Trial with SYL040012 to Treat Elevated Intraocular Pressure and Glaucoma
8. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
9. Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes
10. Sinapis Pharma Commences Phase I Trial
11. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... Emergency Critical Care, a LifeCentre partner practice, located at 165 Fort ... first in Loudoun County to receive a ... M. Barnes , Medical Director, is a well-seasoned veterinarian of more ... , are avid scuba divers. "As altitude skiers and hikers, we ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... ROCHESTER, N.Y., Feb. 2, 2011 VirtualScopics, Inc. (Nasdaq: ... clinical trials, announced today that Mr. Jeff Markin, the company,s ... overview at the upcoming 13th Annual BIO CEO & Investor ... Markin,s presentation will be on Monday, February 14, 2011 at ...
... 2, 2011 Sonoma Orthopedic Products announced that ... agreement with Ai-Medic, a subsidiary of Olympus® Business ... orthopedic products in the Japanese market, especially in ... includes significant license fee and revenue commitments. ...
Cached Medicine Technology:VirtualScopics to Present at the 13th Annual BIO CEO & Investor Conference 2
(Date:7/9/2014)... Researchers at the Perelman School of Medicine at the ... Cancer Institute have received an $8 million grant from ... of photodynamic light therapy (PDT) in patients with malignant ... most often manifests itself in the lining of the ... asbestos. The grant will fund a clinical trial and ...
(Date:7/9/2014)... into the metabolism of stromal support cells and immune ... these cell types in the development of diseases ... and cancer. That was the conclusion of a review ... the leading journal Nature . , Prof. Peter ... call. The metabolism of cancer cells has been examined ...
(Date:7/9/2014)... N.Y. Although feelings are personal and subjective, ... code that objectively represents emotions across different senses, ... by Cornell University neuroscientist Adam Anderson. , "We ... the orbitofrontal cortex, an area of the brain ... code which captures an individual,s subjective feeling," says ...
(Date:7/9/2014)... World Cup highlights, Brian Williams refreshing old school rap ... on railings. A University of Colorado Cancer Center study ... that YouTube also allows researchers, journals, and health advocates ... skin cancer and prevention. , "No matter what field ... we communicate around the world," says Chante Karimkhani, MD ...
(Date:7/9/2014)... print and poor printing on prescription labels handed ... lead to errors in taking medication, according to ... CNIB (Canadian National Institute for the Blind)., The ... Journal , found that labels on prescription medications ... recommended guidelines for legibility. , By simply following ...
Breaking Medicine News(10 mins):Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Wake-up call for more research into cell metabolism 2Health News:Study cracks how the brain processes emotions 2Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... and tolerable exercise can be given to children's with ... a better heart function//. The study was conducted in ... Rhodes. ,The study was conducted in 16 ... with severe congenital heart disease and were given a ...
... proposed by a study by Florian Koppelstatter, University Hospital Innsbruck ... with 100 mg caffeine can boost short-term memory.// ,The ... aged 26 to 47. Participants were tested when they consumed ... 100 mg caffeine can be found in two cups of ...
... presented by Austrian researchers at the annual meeting of ... Friday say that caffeine has the ability to boost ... brain that control this activity. ,Caffeine is ... drinks and chocolate. The researchers tested 15 subjects who ...
... born with a hearing in both ears in India, but she ... year as result of a successful cochlear implant when she was ... was three months old. But they did not lose heart and ... she behaves like any other normal child. ,"Sonam is one ...
... 6 December 2005, along with his wife Melinda. Chennai and ... he reviews the progress of his $200 million HIV/AIDS initiative ... list of Microsoft. Gates' fourth visit in two years will ... key government officials in addition to business leaders, academicians, industry ...
... The Singapore Health Ministry said that they will be raising ... Balaji Sadasivan, Minister of State for Health has asked the ... thousands of women and children infected with HIV. It is ... singapore are married and reports say that there could be ...
Cached Medicine News:Health News:Early Intervention Required For The Hearing Impaired 2Health News:Bill Gates Takes Personal Interest in AIDS Program 2
Used in stat or routine procedures utilizing the dip or rack method of staining blood smears or as a counter-stain in reticulocyte counting. Comes as a part of a kit (8 oz each), or in 16 oz, 32 oz a...
Our Reticulocyte Stain is a specialized hematology stain for identifying immature erythrocytes. These immature erythrocytes stain blue in a fine mesh network within the erythrocyte. Mature erythrocyt...
... Wright-Giemsa Stain is a single ... fixative, buffer, and stain for ... blood smears. It is packaged ... ease of use and is ...
This Wright-Giemsa is a dual-use stain for peripheral blood and bone marrow smears. It produces somewhat darker results when compared with Giemsa, particularly in the blue to magenta shades....
Medicine Products: